A Harsher Look at California's Stem Cell Program: No More Cash Without Changes
By David Jensen,
California Stem Cell Report [cites CGS' Pete Shanks]
| 08. 23. 2018
California's $3 billion stem cell experiment received a host of accolades last week at a state legislative hearing, but one strong, critical voice was not heard in the proceedings.
That came from the Biopolitical Times, a blog operated by the Center for Genetics and Society of Berkeley, a longtime foe of the agency.
In a piece written by Pete Shanks, the agency was taken to task for a number of reasons. And he argued that it should not receive additional funds as it is presently constituted.
Shanks wrote,
"At one time, CIRM had a deserved reputation for funding buildings , some of them at private universities, and was heavily criticized for that, but the $270 million “major facilities” budget approved in 2008 has all been spent. Some of the conflict of interest scandals are largely in the past, though ripples persist , and some of the institutional ones remain; several universities that receive large grants are still represented on the board . But there has been a new regime in place (“CIRM 2.0”) for several...
Related Articles
By Chia-Yi Hou, The Scientist | 04.08.2019
Last week marked a flurry of activity to rein in activities by stem cell clinics that give customers unproven interventions. On Wednesday (April 3), the Food and Drug Administration sent letters to 20 companies providing stem cell treatments, reports The...
By Antonio Regalado, MIT Technology Review | 03.26.2019
Since its invention, CRISPR has let scientists introduce DNA changes at specific locations in a genome. Often these precise changes are made one at a time.
Perhaps not for much longer. A team at Harvard University says it has...
By Kate Sheridan, STAT | 03.04.2019
For the second time, doctors appear to have put HIV into “sustained remission” with a stem cell transplant — effectively curing the recipient.
Their work, which was published in Nature and will be presented at the annual Conference on Retroviruses...
The California Institute for Regenerative Medicine (CIRM) has now spent almost all of the $3 billion of public funds (which entailed a further $3 billion in interest) allotted to it by a 2004 ballot initiative. The CIRM board seems to have no appetite for closing up shop; no better idea than to support another, even larger, ballot initiative that might lead to funds in 2021; and so far, not much of a plan for getting from here to there. But...
